These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10227331)

  • 61. Biology of IL-5 in health and disease.
    Lalani T; Simmons RK; Ahmed AR
    Ann Allergy Asthma Immunol; 1999 Apr; 82(4):317-32; quiz 332-3. PubMed ID: 10227331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin-10: biology, role in inflammation and autoimmunity.
    Lalani I; Bhol K; Ahmed AR
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):469-83. PubMed ID: 9433360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of the interleukin 5 receptor system in hematopoiesis: molecular basis for overlapping function of cytokines.
    Tominaga A; Takaki S; Hitoshi Y; Takatsu K
    Bioessays; 1992 Aug; 14(8):527-33. PubMed ID: 1365906
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Eosinophil differentiation factor (interleukin-5).
    Sanderson CJ
    Immunol Ser; 1990; 49():231-56. PubMed ID: 2090253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Interleukin-5].
    Yamaguchi Y
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1287-93. PubMed ID: 8031174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interleukins in immunologic and allergic diseases.
    Herrod HG
    Ann Allergy; 1989 Oct; 63(4):269-72. PubMed ID: 2679243
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of IL-9 in the pathophysiology of allergic diseases.
    Soussi-Gounni A; Kontolemos M; Hamid Q
    J Allergy Clin Immunol; 2001 Apr; 107(4):575-82. PubMed ID: 11295641
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interleukin-10 therapy--review of a new approach.
    Asadullah K; Sterry W; Volk HD
    Pharmacol Rev; 2003 Jun; 55(2):241-69. PubMed ID: 12773629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine recognition by human interleukin 5 receptor.
    Ishino T; Robertson N; Chaiken I
    Vitam Horm; 2005; 71():321-44. PubMed ID: 16112273
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-5 and eosinophilia.
    Takatsu K; Nakajima H
    Curr Opin Immunol; 2008 Jun; 20(3):288-94. PubMed ID: 18511250
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The biology of interleukin-5 and its receptor.
    Mahanty S; Nutman TB
    Cancer Invest; 1993; 11(5):624-34. PubMed ID: 8402230
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Eosinophilia and interleukin-5: role in pulmonary atopic processes].
    Druilhe A; Pretolani M
    Med Trop (Mars); 1998; 58(4 Suppl):437-43. PubMed ID: 10410362
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetics of allergy and asthma.
    Borish L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):413-24; quiz 424-6. PubMed ID: 10353570
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IL-5- and eosinophil-mediated inflammation: from discovery to therapy.
    Kouro T; Takatsu K
    Int Immunol; 2009 Dec; 21(12):1303-9. PubMed ID: 19819937
    [TBL] [Abstract][Full Text] [Related]  

  • 77. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
    Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting IL-23 in human diseases.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Targets; 2010 Jul; 14(7):759-74. PubMed ID: 20536413
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-5, a therapeutic target in allergic inflammation.
    Huston DP; Huston MM; Dickason RR; Martinez-Moczygemba M
    Trans Am Clin Climatol Assoc; 2000; 111():46-59; discussion 59-60. PubMed ID: 10881331
    [No Abstract]   [Full Text] [Related]  

  • 80. Biological and molecular characteristics of interleukin-5 and its receptor.
    Karlen S; De Boer ML; Lipscombe RJ; Lutz W; Mordvinov VA; Sanderson CJ
    Int Rev Immunol; 1998; 16(3-4):227-47. PubMed ID: 9505190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.